Metabolism of styrene in the human liver in vitro:: interindividual variation and enantioselectivity
Metabolism of styrene in the human liver in vitro:: interindividual variation and enantioselectivity
复制标题
DOI:
10.1080/00498250010031638
复制
发表时间:
2001-02-01
期刊:
影响因子:
1.8
通讯作者:
De Wolff, FA
中科院分区:
文献类型:
--
作者:
Wenker, MAM;Kezic, S;De Wolff, FA
1. The interindividual variation and enantioselectivity of the in vitro styrene oxidation by cytochrome P450 have been investigated in 20 human microsomal liver samples. Liver samples were genotyped for the CYP2E1*6 and CYP2E1*5B alleles.2. Kinetic analysis indicated the presence of at least two forms of styrene-metabolizing cytochrome P450. The enzyme constants for the high-affinity component were subject to appreciable interindividual variation, i.e. V-max1 ranged from 0.39 to 3.20 nmol mg protein(-1) min(-1) (0.96 +/- 0.63) and K-m1 ranged from 0.005 to 0. 03 mM (0.011 +/- 0.006). Inhibition studies with chemical inhibitors of CYP2E1, CYP1A2, CYP2C8/9 and CYP3A4 demonstrated that CYP2E1 was the primary enzyme involved in the high-affinity component of styrene oxidation. No relationship between the interindividual variation in V-max1 and K-m1 and the genetic polymorphisms of the CYP2E1 gene was found.3. Cytochrome P450-mediated oxidation of styrene demonstrated a moderate enantioselectivity, with an enantiomeric excess (ee) of (S)-styrene oxide of 15% (range 4-27%) at low styrene concentration and an ee of (R)-styrene oxide of 7% (range -11 to +22%) at high styrene concentration. This points towards the involvement of at least two cytochrome P450, with different enantioselectivities.4. The data indicate that cytochrome P450-mediated styrene oxidation is subject to considerable interindividual variation, but only to a moderate product enantioselectivity.